What is Insmed's investing cash flow?

Insmed (INSM) reported investing cash flow of $265.52M in Q1 2026.

How has Insmed's investing cash flow changed year-over-year?

Insmed's investing cash flow increased by 230.2% year-over-year, from $80.41M to $265.52M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Insmed INSM Investing Cash Flow

Investing Cash Flow at other companies

Sarepta Therapeutics, Inc.SRPT

-$134.39M+53.8%

United TherapeuticsUTHR

$743.7M+552%

Solid Biosciences Inc.SLDB

$44.76M+263%

ANI PharmaceuticalsANIP

-$11.32M+42.9%

Regeneron PharmaceuticalsREGN

-$428.9M-166%

SavaraSVRA

$38.78M+32.2%

Other financials

Income statement

See full

Revenue$306.0M+230%

Gross profit$258.5M+261%

Operating income-$153.3M+38.2%

Net income-$163.6M+36.3%

EPS (diluted)-$0.76+46.5%

Balance sheet

See full

Cash & equivalents$582.2M+44.4%

Total debt$580.3M-49.2%

Total equity$704.9M+611%

Total assets$2.1B+15.2%

Cash flow

See full

Operating cash flow-$222.7M+15.0%

CapEx$3.5M-65.4%

Free cash flow-$226.2M+16.9%

Valuation

See full

Market cap$23.11B+17.6%

Enterprise value$23.11B+22.0%

P/S28.2×-21.1×

Profitability

See full

Gross margin81.8%+5.3pp

Operating margin-140.6%-43.9pp

Net margin-144.4%-45.3pp

FCF margin-112.5%-35.3pp

Returns & leverage

See full

Return on equity-294.5%—

Debt / equity0.8×-10.7×

Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's investing cash flow?: Insmed (INSM) reported investing cash flow of $265.52M in Q1 2026.
How has Insmed's investing cash flow changed year-over-year?: Insmed's investing cash flow increased by 230.2% year-over-year, from $80.41M to $265.52M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.